Your browser doesn't support javascript.
loading
Sodium-glucose cotransporter 2 inhibitors and heart failure decompensation: considerations on body composition and skeletal mass. Authors' reply.
Budzynski, Jacek; Wawrzenczyk, Anna.
Affiliation
  • Budzynski J; Department of Vascular and Internal Diseases, Nicolaus Copernicus University in Torun, Torun, Poland, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland; Department of Angiology, Jan Biziel University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland. jb112233@cm.umk.pl
Pol Arch Intern Med ; 131(12)2021 12 22.
Article in En | MEDLINE | ID: mdl-34937328
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Pol Arch Intern Med Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: En Journal: Pol Arch Intern Med Year: 2021 Document type: Article Affiliation country: Country of publication: